Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI

OBJECTIVES: To compare definitions of high disease activity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in selecting patients for treatment with biologic disease-modifying antirheumatic drugs (bDMARDs). METHODS: Patient...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:RMD Open
Päätekijät: Marona, Jose, Sepriano, Alexandre, Rodrigues-Manica, Santiago, Pimentel-Santos, Fernando, Mourão, Ana Filipa, Gouveia, Nélia, Branco, Jaime Cunha, Santos, Helena, Vieira-Sousa, Elsa, Vinagre, Filipe, Tavares-Costa, João, Rovisco, João, Bernardes, Miguel, Madeira, Nathalie, Cruz-Machado, Rita, Roque, Raquel, Silva, Joana Leite, Marques, Mary Lucy, Ferreira, Raquel Miriam, Ramiro, Sofia
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2020
Aiheet:
Spondyloarthritis
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7061099/
https://ncbi.nlm.nih.gov/pubmed/32144137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2019-001145
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia